Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency launches public catalogue of medicine shortages assessed by the Agency 4 November 2013NewsCorporateMedicines European Medicines Agency and US Food and Drug Administration release further guidance on quality-by-design approach 4 November 2013NewsCorporateMedicines Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders and changes to scope of European safety referrals 31 Oktober 2013NewsCorporate Comments invited on concept paper on the need to revise the guideline on medicines to treat Alzheimer's disease 31 Oktober 2013NewsHumanRegulatory and procedural guidance Workshop on biosimilars takes place today 31 Oktober 2013NewsCorporateBiosimilars European Medicines Agency closed on 1 November 2013 30 Oktober 2013NewsCorporateMedicines European Medicines Agency explores ways to further involve patients in the benefit-risk assessment of medicines 29 Oktober 2013NewsCorporateMedicines Revision of paediatric-investigation-plan guideline: stakeholder comments sought by European Commission 28 Oktober 2013NewsCorporateRegulatory and procedural guidance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 October 2013 25 Oktober 2013NewsHuman European Medicines Agency gives recommendations on the use of intravenous nicardipine 25 Oktober 2013Press releaseHumanMedicines 1 … 214 215 216 217 218 Page 218 of 384 219 220 221 222 … 384
European Medicines Agency launches public catalogue of medicine shortages assessed by the Agency 4 November 2013NewsCorporateMedicines
European Medicines Agency and US Food and Drug Administration release further guidance on quality-by-design approach 4 November 2013NewsCorporateMedicines
Amendments to the pharmacovigilance legislation: new notification requirements for marketing-authorisation holders and changes to scope of European safety referrals 31 Oktober 2013NewsCorporate
Comments invited on concept paper on the need to revise the guideline on medicines to treat Alzheimer's disease 31 Oktober 2013NewsHumanRegulatory and procedural guidance
European Medicines Agency explores ways to further involve patients in the benefit-risk assessment of medicines 29 Oktober 2013NewsCorporateMedicines
Revision of paediatric-investigation-plan guideline: stakeholder comments sought by European Commission 28 Oktober 2013NewsCorporateRegulatory and procedural guidance
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 October 2013 25 Oktober 2013NewsHuman
European Medicines Agency gives recommendations on the use of intravenous nicardipine 25 Oktober 2013Press releaseHumanMedicines